Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vibrio cholerae O1 surface antigen is a key component of the bacterium's outer membrane lipopolysaccharide (LPS), defining the O1 serogroup responsible for epidemic and pandemic cholera. It functions as a phage receptor, a major target for host immune responses, and contributes to bacterial virulence by protecting against complement-mediated killing and facilitating colonization. Vaccines targeting this antigen aim to elicit protective immunity.
Neutralization of bacteria, complement-mediated killing, stimulation of antibody production.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 Surface Antigen (O1 Antigen).